These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 29057565)
1. Spectrophotometer is useful for assessing vitiligo and chemical leukoderma severity by quantifying color difference with surrounding normally pigmented skin. Hayashi M; Okamura K; Araki Y; Suzuki M; Tanaka T; Abe Y; Nakano S; Yoshizawa J; Hozumi Y; Inoie M; Suzuki T Skin Res Technol; 2018 May; 24(2):175-179. PubMed ID: 29057565 [TBL] [Abstract][Full Text] [Related]
2. An immune pathological and ultrastructural skin analysis for rhododenol-induced leukoderma patients. Tanemura A; Yang L; Yang F; Nagata Y; Wataya-Kaneda M; Fukai K; Tsuruta D; Ohe R; Yamakawa M; Suzuki T; Katayama I J Dermatol Sci; 2015 Mar; 77(3):185-8. PubMed ID: 25676426 [TBL] [Abstract][Full Text] [Related]
3. Differences in the melanosome distribution within the epidermal melanin units and its association with the impairing background of leukoderma in vitiligo and halo nevi: a retrospective study. Xiong XX; Ding GZ; Zhao WE; Li X; Ling YT; Sun L; Gong QL; Lu Y Arch Dermatol Res; 2017 Jul; 309(5):323-333. PubMed ID: 28314912 [TBL] [Abstract][Full Text] [Related]
4. Leukoderma induced by rhododendrol is different from leukoderma of vitiligo in pathogenesis: A novel comparative morphological study. Tsutsumi R; Sugita K; Abe Y; Hozumi Y; Suzuki T; Yamada N; Yoshida Y; Yamamoto O J Cutan Pathol; 2019 Feb; 46(2):123-129. PubMed ID: 30456919 [TBL] [Abstract][Full Text] [Related]
5. A unique system that can sensitively assess the risk of chemical leukoderma by using murine tail skin. Iida M; Tazaki A; Deng Y; Chen W; Yajima I; Kondo-Ida L; Hashimoto K; Ohgami N; Kato M Chemosphere; 2019 Nov; 235():713-718. PubMed ID: 31279121 [TBL] [Abstract][Full Text] [Related]
6. Open-label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol-induced refractory leukoderma. Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Tada Y; Watanabe S J Dermatol; 2018 Nov; 45(11):1283-1288. PubMed ID: 30156328 [TBL] [Abstract][Full Text] [Related]
7. Possible involvement of CCR4+ CD8+ T cells and elevated plasma CCL22 and CCL17 in patients with rhododenol-induced leukoderma. Nishioka M; Tanemura A; Yang L; Tanaka A; Arase N; Katayama I J Dermatol Sci; 2015 Mar; 77(3):188-90. PubMed ID: 25766765 [No Abstract] [Full Text] [Related]
8. Application of a pigment measuring device--Mexameter--for the differential diagnosis of vitiligo and nevus depigmentosus. Park ES; Na JI; Kim SO; Huh CH; Youn SW; Park KC Skin Res Technol; 2006 Nov; 12(4):298-302. PubMed ID: 17026663 [TBL] [Abstract][Full Text] [Related]
9. Cultured epidermal autografts for treatment of stable vitiligo: Quantitative analysis of color matching with surrounding normally pigmented skin. Toriyama K; Kato H; Sato H; Tanaka T; Inoie M; Morita A J Dermatol; 2021 Sep; 48(9):1405-1408. PubMed ID: 34169570 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of different factors influencing objective measurement of skin color by colorimetry. Anbar TS; Eid AA; Anbar MT Skin Res Technol; 2019 Jul; 25(4):512-516. PubMed ID: 30758882 [TBL] [Abstract][Full Text] [Related]
11. Possible mechanisms of hypopigmentation in lichen sclerosus. Carlson JA; Grabowski R; Mu XC; Del Rosario A; Malfetano J; Slominski A Am J Dermatopathol; 2002 Apr; 24(2):97-107. PubMed ID: 11979069 [TBL] [Abstract][Full Text] [Related]
12. Substantial evidence for the rhododendrol-induced generation of hydroxyl radicals that causes melanocyte cytotoxicity and induces chemical leukoderma. Gabe Y; Miyaji A; Kohno M; Hachiya A; Moriwaki S; Baba T J Dermatol Sci; 2018 Sep; 91(3):311-316. PubMed ID: 30005897 [TBL] [Abstract][Full Text] [Related]
14. Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma. Tokura Y; Fujiyama T; Ikeya S; Tatsuno K; Aoshima M; Kasuya A; Ito T J Dermatol Sci; 2015 Mar; 77(3):146-9. PubMed ID: 25726326 [TBL] [Abstract][Full Text] [Related]
15. Clinical and epidemiological analysis in 149 cases of rhododendrol-induced leukoderma. Yoshikawa M; Sumikawa Y; Hida T; Kamiya T; Kase K; Ishii-Osai Y; Kato J; Kan Y; Kamiya S; Sato Y; Yamashita T J Dermatol; 2017 May; 44(5):582-587. PubMed ID: 27882588 [TBL] [Abstract][Full Text] [Related]
16. Vitiliginous lesions induced by amyl nitrite exposure. Vine K; Meulener M; Shieh S; Silverberg NB Cutis; 2013 Mar; 91(3):129-36. PubMed ID: 23617083 [TBL] [Abstract][Full Text] [Related]
17. Rhododendrol-induced leukoderma update II: Pathophysiology, mechanisms, risk evaluation, and possible mechanism-based treatments in comparison with vitiligo. Inoue S; Katayama I; Suzuki T; Tanemura A; Ito S; Abe Y; Sumikawa Y; Yoshikawa M; Suzuki K; Yagami A; Masui Y; Ito A; Matsunaga K J Dermatol; 2021 Jul; 48(7):969-978. PubMed ID: 33951216 [TBL] [Abstract][Full Text] [Related]
18. Histopathologic features in vitiligo. Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112 [TBL] [Abstract][Full Text] [Related]
19. Confetti-like depigmentation: A potential sign of rapidly progressing vitiligo. Sosa JJ; Currimbhoy SD; Ukoha U; Sirignano S; O'Leary R; Vandergriff T; Hynan LS; Pandya AG J Am Acad Dermatol; 2015 Aug; 73(2):272-5. PubMed ID: 26054430 [TBL] [Abstract][Full Text] [Related]
20. In vivo reflectance confocal microscopy imaging of vitiligo, nevus depigmentosus and nevus anemicus. Lai LG; Xu AE Skin Res Technol; 2011 Nov; 17(4):404-10. PubMed ID: 21429011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]